Compare VREX & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VREX | BBNX |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.9M | 493.1M |
| IPO Year | 2016 | N/A |
| Metric | VREX | BBNX |
|---|---|---|
| Price | $10.35 | $15.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $16.67 | ★ $23.80 |
| AVG Volume (30 Days) | 335.8K | ★ 1.0M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $811,000,000.00 | N/A |
| Revenue This Year | $5.35 | $34.90 |
| Revenue Next Year | $3.88 | $34.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.76 | $8.80 |
| 52 Week High | $14.57 | $32.71 |
| Indicator | VREX | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 71.10 |
| Support Level | $10.18 | $9.34 |
| Resistance Level | $12.60 | $32.52 |
| Average True Range (ATR) | 0.52 | 1.03 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 25.84 | 81.72 |
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.